EVAX
USDEvaxion Biotech A/S American Depositary Share
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$5.570
Kõrge
$6.010
Madal
$5.570
Maht
0.09M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
44.4M
Tööstusharu
Biotehnoloogia
Riik
Denmark
Kauplemisstatistika
Keskmine maht
1.59M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate designed for
Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline. COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.